Chronicity of Depression Ups Failure Along Continuum of HIV Care

Share this content:
Chronicity of Depression Ups Failure Along Continuum of HIV Care
Chronicity of Depression Ups Failure Along Continuum of HIV Care

THURSDAY, Feb. 22, 2018 (HealthDay News) -- Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care, according to a study published online Feb. 21 in JAMA Psychiatry.

Brian W. Pence, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues examined the correlation between increased chronicity of depression and multiple HIV care continuum indicators in an observational clinical cohort of 5,927 patients with two or more assessments of depressive severity. Participants were receiving HIV care at six geographically dispersed U.S. academic medical centers.

The researchers found that the median percentage of days with depression (PDD) was 14 percent during 10,767 person-years of follow-up. During follow-up, 18.8 percent of scheduled visits were missed, 21.8 percent of viral loads were detectable, and the mortality rate was 1.5 deaths for 100 person-years; a dose-response relationship was seen for PDD with each outcome. Each 25 percent increase in PDD led to significant increases in the risk of missing a scheduled appointment (risk ratio, 1.08), a detectable viral load (risk ratio, 1.05), and mortality (hazard ratio, 1.19).

"Clinic-level trials of protocols to promptly identify and appropriately treat depression among adults living with HIV should be conducted to understand the effect of such protocols on shortening the course and preventing the recurrence of depressive illness and improving clinical outcomes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »